In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In recent decades, the cancer research community has made great strides by bringing new, targeted, safer, and longer-lasting treatments...
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....
September is Ovarian Cancer Awareness Month. It’s an apt time for the American Association for Cancer Research (AACR) Advances...
When new cells are needed to replace old, worn-out cells in our organs and tissues, the DNA that encodes...
Back for the final push of summer are the editors’ picks from the eight peer-reviewed scientific journals published by...
Policy plays a critical role in the fight against cancer, influencing the funding of cancer research and driving the...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
The AACR Project Genomics Evidence Neoplasia Information Exchange (AACR Project GENIE) is a unique registry that aggregates, harmonizes, and...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
Cancer is very complex, and the tools that we need to understand how it develops and progresses come from...